Centr Brands (CNTRF) Stock Price, News & Analysis
Company Description
Centr Brands (OTC Link: CNTRF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $176.0K.
CNTRF has gained 3.9% over the past year. Shares last traded at $0.0430.
This page collects what Stock Titan holds for CNTRF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Centr Brands (CNTRF) stock last closed at $0.0430. Over the past 12 months, the stock has gained 3.9%. At a market capitalization of $176.0K, CNTRF is classified as a micro-cap stock with approximately 11.6M shares outstanding.
Latest News
Centr Brands has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include management. View all CNTRF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Centr Brands (CNTRF) currently stands at 215 shares, down 18.9% from the previous reporting period, representing 0.0% of the float. Since September 2025, short interest has decreased by 18.9%. This relatively low short interest suggests limited bearish sentiment. With 19.6 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Centr Brands (CNTRF) currently stands at 19.6 days, down 98% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 1855% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
CNTRF Company Profile & Sector Positioning
Centr Brands (CNTRF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CNTRF often look at related companies in the same sector, including Xebra Brands (XBRAF), Canntab Therapeutics Ltd (CTABF), Pineapple Express Cannabis Co (PNXP), Golden Developin (DVLP), and Noveris Health Sciences Inc (MYCOF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNTRF's relative position within its industry.